BERTRAND TILLERY: Open Payments
NPI 1700852241 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 41 payments from 13 companies in 2025. Trend: 2023 $1,122 · 2024 $927 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $212 |
| Corcept Therapeutics | 7 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $193 |
| ABBVIE INC. | 10 | $153 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| TOLMAR, INC. | 1 | $18 |
Products named: Korlym, Kerendia, Otezla, VRAYLAR, BREZTRI, UBRELVY, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
